Research view
Dermatomyositis and polymyositis (myositis): who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
EU-13 is a filter, not a ranking: it only narrows the list.
No research groups match this view yet.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Withdrawn
Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
“No participants.”Registry text, quoted unchanged. Source
Terminated
Study of M5049 in DM and PM Participants (NEPTUNIA)
“Based on interim analyses for futility”Registry text, quoted unchanged. Source
Withdrawn
“Plan change: Plan to add a center”Registry text, quoted unchanged. Source
Terminated
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
“The study was closed due to continued enrollment hurdles.”Registry text, quoted unchanged. Source
Suspended
A Study of BEN301 Injection in theTreatment of Autoimmune Diseases
“company's decision”Registry text, quoted unchanged. Source
Withdrawn
Pregnancy and Medically Assisted Conception in Rare Diseases
“Abandonment of the study project”Registry text, quoted unchanged. Source
Withdrawn
A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases
“Business Decision”Registry text, quoted unchanged. Source
Suspended
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases
“R\&D strategy adjustment”Registry text, quoted unchanged. Source
Terminated
“The collaborating party has adjusted its R\&D strategy and terminated the study.”Registry text, quoted unchanged. Source
Terminated
“Primary endpoint not attained”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.